Molecular Imaging: Page 438

Canadian government to stop development of Maple reactors

By AuntMinnie.com staff writers

Atomic Energy of Canada (AECL) has announced that it will discontinue development of two Maple medical-isotope-dedicated reactors at Chalk River Laboratories in Ontario, effective immediately.

May 15, 2008

ImaRx posts revenue growth in Q1

By AuntMinnie.com staff writers

Biopharmaceutical company ImaRx Therapeutics of Tucson, AZ, reported revenue gains for the first quarter of 2008.

May 15, 2008

Molecular Insight's revenue decreases in Q1

By AuntMinnie.com staff writers

Molecular Insight Pharmaceuticals of Cambridge, MA, has posted financial results for its first quarter of 2008.

May 13, 2008

PETNet gets U.K. FDG license

By AuntMinnie.com staff writers

Siemens Healthcare said that its PETNet Solutions division has received a full Marketing Authorization and Manufacturer's/Importer's (MIA) license to produce and distribute its FDG biomarker from its Nottingham City Hospital site.

May 11, 2008

Revenues slip, loss posted in Draxis' Q1

By AuntMinnie.com staff writers

Lower sales of sterile products, the negative impact of a stronger Canadian dollar, and costs related to the potential sale of the company combined to stymie growth at Draxis Health in the first quarter.

May 8, 2008

Study evaluates radiation dose, cancer risk for whole-body PET/CT

By Wayne Forrest

A new study from Hong Kong suggests that whole-body PET/CT scans and excessive radiation doses can increase the risk of cancer, especially among young patients and women. The researchers also offer effective CT radiation doses for men and women, as well as effective doses for combined PET/CT procedures.

May 8, 2008